Clinical studies with angiogenesis inhibitors: Biological rationale and challenges for their evaluation

Annals of Oncology

Volumn 7, Issue 5, 1996, Pages 441-444

  Gasparini, G ^a   Presta, M ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; TECOGALAN;

ANGIOGENESIS; CANCER CHEMOTHERAPY; CLINICAL TRIAL; EDITORIAL; ENDOTHELIUM CELL; HUMAN; PRIORITY JOURNAL;

EID: 0030036156     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010631     Document Type: Editorial

References (45)

1. Shackney S.E. Pollice A.A. Smith C.A. The accumulation of multiple genetic abnormalities in individual tumor cells in human breast cancers: Clinical prognostic implications Cancer J Sci Am 2 1996 106 113
2. Liu B. Farrington S.M. Petersen G.M. Genetic instability occurs in the majority of young patients with colorectal cancer Nature Med 1 1995 348 352
3. Heppner G.H. Tumor cell societies J Natl Cancer Inst 81 1989 648 649
4. Schilsky R.L. Tumor cell heterogeneity: Implications for clinical practice Semin Oncol 12 1985 203 206
5. Endicott J. Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance Annu Rev Biochem 58 1989 137 171
6. Gottesman M.H. How cancer cells evade chemotherapy (Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture) Cancer Res 53 1993 747 754
7. Simon S.M. Schinder M. Cell biological mechanisms of multidrug resistance in tumors Proc Natl Acad Sci USA 91 1994 3497 3504
8. Dvorak H.F. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing N Engl J Med 315 1986 1650 1659
9. Fidler I.J. Modulation of the organ microenvironment for treatment of cancer metastasis J Natl Cancer Inst 87 1995 1588 1592
10. Iozzo R.V. Tumor stroma as a regulator of neoplastic behaviour Lab Invest 73 1995 157 160
11. Horwitz A.F. Thiery J.P. Cell-to-cell contact and extracellular matrix Cell Biol 6 1994 205 207
12. Van den Hoof A. The role of stromal cells in tumor metastasis. A new link Cancer Cells 3 1991 186 187
13. Stetler-Stevenson W.G. Aznavoorian S. Liotta L.A. Tumor cell interactions with extracellular matrix during invasion and metastasis Annu Rev Cell Biol 9 1993 541 573
14. Roskelly C.D. Desprez P.Y. Bissel M.J. Extracellular matrix-dependent tissue specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction Proc Natl Acad Sci USA 91 1994 12378 12382
15. Sankar S. Mahooti-Brooks N. Bensen L. Modulation of transforming growth factor ß receptor levels on microvascular endothelial cells during in vitro angiogenesis J Clin Invest 97 1996 1436 1446
16. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Med 1 1995 27 31
17. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 82 1989 4 6
18. Fidler I.J. Ellis L.M. The implications of angiogenesis for the biology and therapy of cancer metastasis Cell 29 1994 185 188
19. Folkman J. Clinical applications of research on angiogenesis N Engl J Med 333 1995 1757 1763
20. McCulloch P. Choy A. Martin L. Association between tumor angiogenesis and tumor cell shedding into effluent venous blood during breast cancer surgery Lancet 96 1995 1696 1697
21. Folkman J. Tumor angiogenesis and tissue factor Nature Med 2 1996 167 168
22. Modzelewski R.A. Davies P. Watkins S.C. Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma Cancer Res 54 1994 336 339
23. Kerbel R.S. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents Bio Essays 13 1991 31 36
24. Denekamp J. The current status of targeting tumour vasculature as a means of cancer therapy: An overview Int J Radiat 60 1991 401 408
25. Fox S.B. Gatter C. Bicknell R. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer Cancer Res 53 1993 4161 4163
26. Burrows F.J. Derbyshire J. Tazzari P.L. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: Implications for diagnosis and therapy Clin Cancer Res 1 1995 1632 1634
27. Rak J.W. Croix B.D.S. Kerbel R.S. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy 6 1995 3 18 Anti-Cancer Drugs
28. Cordon-Cardo C. O’Brein J.P. Boccia J. Expression of the multidrug resistance gene product (P–glycoprotein) in human normal and tumor tissues J Histochem Cytochem 38 1990 1277 1287
29. Terrier P. Townsend A.J. Coindre J.M. An immunohisto-chemical study of Pi class glutathione S-transferase expression in normal human tissues Am J Pathol 137 1990 845 853
30. Gasparini G. Bevilacqua P. Bonoldi E. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy Clin Cancer Res 1 1995 1375 1383
31. Folkman J. Tumor angiogenesis: Therapeutic implications N Engl J Med 285 1971 1182 1186
32. Auerbach W. Auerbach R. Angiogenesis inhibitors; A review Pharmacol Ther 63 1994 265 311
33. Eckhardt S.G. Burris H.A. Eckhardt J.R. A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium Ann Oncol 7 5 1996 491 496 (this issue)
34. Basilico C. Moscatelli D. The FGF family of growth factors and oncogenes Adv Cancer Res 59 1992 115 165
35. Johnson D.E. Williams L.T. Structural and functional diversity in FGF receptor multigene family Adv Cancer Res 66 1993 1095 1104
36. Gualandris A. Urbinati C. Rusnati M. Interaction of high molecular weight basic fibroblast growth factor (bFGF) with endothelium: Biological activity and intracellular fate of human recombinant Mr24,000 bFGF J Cell Physiol 161 1994 149 159
37. Moscatelli D. Presta M. Joseph-Silverstein J. Both normal and tumor cells produce basic fibroblast growth factor J Cell Physiol 129 1986 273 276
38. Hori A. Sasada R. Matsutani E. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor Cancer Res 51 1991 6180 6184
39. Rusnati M. Presta M. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans: Biological implications in neovascularization Int J Clin Lab Res 1996 in press
40. Schulze-Osthoff K. Risau W. Vollmer E. In situ detection of basic fibroblast growth factor by highly specific antibodies Am J Pathol 137 1990 85 92
41. Toi M. Endothelial growth factors; A target for antiangiogenesis Cancer J 8 1995 315 319
42. Nguyen M. Watanabe H. Budson A.E. Elevated levels of an angiogenic peptide, basic fibroblast growth factor in the urine of patients with a wide spectrum of cancers J Natl Cancer Inst 86 1994 356 361
43. Gasparini G. Harris A.L. Clinical implications of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool J Clin Oncol 13 1995 765 782
44. Teicher B.A. Holden S.A. Ara G. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other antiangiogenic agents Int J Cancer 57 1994 920 925
45. Gasparini G. Harris A.L. Does improved control of tumour growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells? Eur J Cancer 30A 1994 201 206